Enhanced Cytotoxicity of RIPTK Gene Therapy of Pancreatic Cancer via PDX-1 Co-Delivery
Authors:
- Xiao-Ping WangXWXiao-Ping Wang
- F. Charles BrunicardiFBF. Charles Brunicardi
- 31 January 2007
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 137 (1) , 1-9
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Epidemiology and Prevention of Pancreatic CancerJapanese Journal of Clinical Oncology, 2004
- Hereditary Pancreatitis as the Premalignant DiseasePancreas, 2004
- Clinical and genetic characteristics of hereditary pancreatitis in EuropeClinical Gastroenterology and Hepatology, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Diabetes: Risk Factor for the Development of Pancreatic Cancer or Manifestation of the Disease?World Journal of Surgery, 2001
- Pancreatic Cancer and Diabetes: Is there a Relationship? A Case‐controlled StudyAnz Journal of Surgery, 2000
- Treatment of advanced and metastatic pancreatic cancerFrontiers in Bioscience-Landmark, 1998
- Gene Therapy for Peritoneal Dissemination of Pancreatic Cancer by Liposome-Mediated Transfer of Herpes Simplex Virus Thymidine Kinase GeneHuman Gene Therapy, 1997
- Pancreatitis is a risk factor for pancreatic cancerGastroenterology, 1995
- Significance of erb B‐2 Gene Product as a Target Molecule for Cancer TherapyScandinavian Journal of Immunology, 1994